Dr. Iswariya Venkataraman is the Director of the Scientific Affairs team at EUROIMMUN US. In this role, she strives to expand the scientific footprint and in turn the commercial market for EUROIMMUN products in the United States. She holds a Ph.D in the field of neuroscience and during her study she identified novel auto-antigens in autoimmune hyper-excitability disorders. She is also designated as an inventor and holds a patent for identification of a methodology for isolating an autoantibody binding to a polypeptide selected from the super family of proteins called “Soluble NSF Attachment Protein Receptor” (SNARE) in patients with selected autoimmune neurological disorders.
Dr. Divyanshu Dubey is an Associate Professor of Neurology at Mayo Clinic, Rochester, MN. His research focus is central and peripheral autoimmune neurological conditions. This includes search for novel autoantibody biomarkers and analysis of clinical features of autoimmune neurological disorders. He has authored more than 120 peer reviewed articles in various high impact factor journals. He has been an invited speaker at multiple national and international conferences
Hesham Abboud, MD, PhD is the Director of the Multiple Sclerosis and Neuroimmunology Program at University Hospitals Cleveland Medical Center and a staff neurologist at the Parkinson’s and Movement Disorders Center. He is an Assistant Professor of Neurology at Case Western Reserve University School of Medicine. Dr. Abboud is board-certified in neurology. His special interests include MS, NMO, autoimmune encephalitis, autoimmune movement disorders, spinal movement disorders, spasticity management, and neuromodulation. Dr. Abboud earned his medical degree from Alexandria University in Egypt where he also completed an internship and a residency in Neurology and Psychiatry. He obtained Masters and Doctorate degrees in Neurology from Alexandria University before joining the Cleveland clinic where he completed a residency in adult neurology, a clinical fellowship in movement disorders and neuromodulation, and a clinical fellowship in multiple sclerosis and neuroimmunology. He received special training in neuromyelitis optica and autoimmune neurology at Johns Hopkins University. Dr. Abboud founded the Multiple Sclerosis and Neuroimmunology Program at University Hospitals Cleveland Medical Center including the first dedicated Neuromyelitis Optica and Autoimmune encephalitis Clinics in North East Ohio. He is active with the Consortium of MS Centers, The NMO International Clinical Consortium, and the Autoimmune Encephalitis Alliance.
Dr. Piquet is a graduate of Penn State University School of Medicine and completed her neurology residency at Harvard’s Neurology Program at Massachusetts General Hospital and Brigham and Women’s Hospital. She completed her Autoimmune Neurology Fellowship at the University of Utah. She is a current Associate Professor of Neurology at the University of Colorado in the Neuroimmunology, Neuroinfectious disease and Neurohospitalist sections and the Associate Program Director of the Neuro-infectious Disease & Autoimmune Neurology Fellowship. As the Director of the Autoimmune Neurology Program, Dr. Piquet has established the autoimmune neurology clinics at the University of Colorado. Dr. Piquet has a clinical research interest in characterizing biomarkers in autoimmune neurological diseases and as part of this effort, she has established the autoimmune neurological disease registry and biorepository at the University of Colorado.
Stacey Clardy MD PHD is an Associate Professor of Neurology at the University of Utah and the Salt Lake City VA. She established the autoimmune neurology clinic at the University of Utah and is the director of the Autoimmune Neurology Fellowship program at Utah. She completed her fellowship training in Autoimmune Neurology at the Mayo Clinic in Rochester, MN.
Dr. Heather Van Mater, MD, MS. is a pediatric rheumatologist, with a particular affinity for the central nervous system. She is the Chief of Pediatric Rheumatology and co-director of the Pediatric Autoimmune Brain Disease (ABD) program at Duke Medical Center where she works closely with colleagues in neurology and psychiatry evaluating and treating inpatients with autoimmune conditions such as autoimmune encephalitis and CNS vasculitis. She is engaged in clinical research in children with AE as she works to better understand disease classification and optimal treatment strategies.
- pediatrics and pediatric neurology residencies at Boston Children's Hospital (2001-2006)
- pediatric multiple sclerosis and neuro-immunology fellowship at Boston Children's, Massachusetts General and Brigham and Women's Hospitals (2006-2008)
- founding director of the Pediatric MS and Neuro-immunology Programs at Boston Children's Hospital (2008-present)
- assistant professor of neurology at Harvard Medical School (2013-present)
Stephen Rush is an associate professor of psychiatry at the University of Cincinnati’s Department of Psychiatry and Behavioral Neuroscience. He attended medical school at Indiana University and did a general psychiatry residency at the University of Cincinnati, graduating in 2014. Since becoming a faculty member in the department he has been involved in the treatment of patients with severe and refractory forms of major depressive disorder, bipolar disorder and schizophrenia spectrum disorders amongst others and receives referrals from various states in the country. He started a transcranial magnetic stimulation clinic at University of Cincinnati Medical Center, which has morphed into a Treatment Resistant Depression program, of which he is the co-director. He is also involved in community outreach, serving on the Tardive Dyskinesia Expert Panel and Clozapine Expert Panel for the Cure SZ Foundation, as well as doing speaking engagements and outreach for the Autoimmune Encephalitis Alliance amongst others. He currently serves as Medical Directory of Ambulatory Services for the UC Department of psychiatry. His clinical practice primarily involves treatment refractory psychiatric illnesses from depression to schizophrenia.
Dr. Pojen Deng obtained his Bachelor of Science degree from Columbia University School of Engineering and completed his medical degree from the Warren Alpert Medical School of Brown University. He then completed dual residency training in neurology and psychiatry at the NYU Medical Center.
He joined the Mount Sinai Health System as a neurohospitalist with additional outpatient practice in neuropsychiatry, where he treats conditions at the interface of neurology and psychiatry with particular interests in neuroimmunology and epilepsy. He also collaborates across the department in clinical research and education.
Steven Vernino, MD, PhD is Professor and Vice Chair of Neurology at UT Southwestern Medical Center. He is director of the autonomic disorders program and the multidisciplinary multiple system atrophy clinic. He holds the Dr. Bob and Jean Smith Foundation Distinguished Chair in Neuromuscular Disease Research and the Rex Griswold Distinguished Professorship in Multiple System Atrophy. Dr. Vernino earned his MD and PhD in Neuroscience at Baylor College of Medicine. He completed neurology residency and fellowship training in neuroimmunology and EMG at Mayo Clinic in Rochester, MN. He is Board Certified in Neurology, Neuromuscular Medicine, and Autonomic Disorders. He currently serves on the board of directors of the American Autonomic Society and the medical advisory boards of the Myasthenia Gravis Foundation, The MSA Coalition, Encephalitis 411 and Dysautonomia International. He is a Fellow of the American Academy of Neurology, American Neurological Association and American Autonomic Society. Dr. Vernino has been recognized as an outstanding clinician, researcher and teacher with numerous awards. He was the 1998 recipient of the AAN Founders Award, 2013 recipient of the AAN program director award, and 2016 Regents Outstanding Teacher Award from the University of Texas system. He is current president of the American Autonomic Society. Dr. Vernino has published over 100 peer-reviewed articles as well as dozens of book chapters. His main research interest has been in treatment of autonomic disorders and in helping to establish the field of autoimmune neurology. Most notably, he identified the presence of antibodies to ganglionic acetylcholine receptors as the cause of a rare disorder of the autonomic nervous system, autoimmune autonomic ganglionopathy, as well as characterizing several neurological antibodies related to paraneoplastic disorders.
Dr. Adrian Budhram obtained his medical degree from McMaster University, followed by residency training in neurology at Western University. He then went on to complete fellowship training in Autoimmune Neurology at the Mayo Clinic in Rochester, Minnesota. He has expertise in both the laboratory diagnosis and clinical management of patients with autoimmune neurological diseases. Alongside the Clinical Immunology Laboratory, Dr. Budhram facilitated the launch of comprehensive neural antibody testing for autoimmune encephalitis at London Health Sciences Centre. He also runs the Autoimmune Neurology Clinic, which specializes in the evaluation of patients with neural antibody-associated diseases that include autoimmune encephalitis, stiff-person spectrum disorders and paraneoplastic neurological syndromes. He has authored over 50 peer-reviewed publications, with his primary research interest being the diagnostic utility of neural antibody testing in clinical practice.
Lisa K. Peterson, PhD, D(ABMLI) is an Assistant Professor of Pathology at the University of Utah School of Medicine and a Medical Director in the Immunology division at ARUP Laboratories, where she oversees testing that aids in the diagnosis of autoimmunity and immune deficiency. She is also the director of the laboratory rotation for Autoimmune Neurology Fellows at the University of Utah.
Dr. Peterson’s research interests include development, evaluation, and validation of assays for the diagnosis and management of immune deficiencies and autoimmune diseases, with a focus on autoimmune neurologic diseases. She is very interested in optimizing test utilization and in understanding factors that drive variability in the performance characteristics of autoantibody tests to optimize both intra- and inter-laboratory correlations to improve patient care. She has authored more than 30 peer-reviewed articles and book chapters and serves as an ad hoc reviewer for a number of clinical and laboratory journals. Dr. Peterson currently serves as secretary of the Association of Medical Laboratory Immunologists (AMLI) as well as chair of the society’s membership committee. In addition to AMLI, she has active membership in AAN, the American Academy of Clinical Chemistry (AACC) and the Clinical Immunology Society (CIS).
Stanley Naides, MD, FACP, FACR is a board-certified internist with subspecialty certification in Rheumatology. He received his Bachelor's degree from Princeton University in Biochemistry and attended the Hebrew University in Jerusalem. He received his M.D. from Drexel University. He trained in Internal Medicine at the University of Miami/Jackson Memorial Hospital and at Temple University. Dr. Naides completed fellowships in rheumatology at the University of California, San Diego and in immunology research at Harvard Medical School. He then joined the Division of Rheumatology, University of Iowa where he became a tenured Associate Professor and was the founding Director of the interdisciplinary Helen C. Levitt Center for Viral Pathogenesis and Disease. Dr. Naides subsequently was Professor of Medicine, Microbiology & Immunology, and Pharmacology at Pennsylvania State University/Milton S. Hershey Medical Center where he held the Hallowell Endowed Chair, was Chief of Rheumatology, and Co-Director of the Immunobiology Graduate Program. In 2006, he joined Quest Diagnostics Nichols Institute as Medical Director, Immunology R&D where his portfolio included new assay development and oversight of reference laboratory clinical testing in immunology, allergy, neuroimmunology, electrophoresis, andrology, and immunology-related flow cytometry. In 2019, he joined EUROIMMUN US in New Jersey as Director of Scientific Affairs where he oversaw research, scientific communications, and publications. In 2019, he returned to his home in California and worked as a consultant in the diagnostic laboratory industry. He recently joined Laboratory Corporation of America, Labcorp, as Medical Science Liaison. His extramurally supported basic and translational research focused on viral pathogenesis and autoimmunity. As a laboratorian in a commercial high complexity test reference laboratory, his research portfolio included test development in rheumatology, neuroimmunology, gastroenterology, allergy, and immunodeficiency. He has served on NIH and foundation grant review study sections and continues to serve on national professional society committees. Dr. Naides is the author/editor of more than 100 peer-reviewed papers, book chapters, books, and reviews.
Michael Racke, MD is the medical director for neurology at Quest Diagnostics. He completed his neurology training at Emory University in Atlanta and a neuroimmunology fellowship at the National Institutes of Health. His research efforts included developing anti-CD20 monoclonal antibodies for multiple sclerosis, including the first publication using rituximab in progressive multiple sclerosis. His research also centers on the pathogenesis of multiple sclerosis. Dr. Racke has served on scientific advisory committees for the National Multiple Sclerosis Society, National Institutes of Health, and the Hertie Foundation. He was recognized as one of the Best Doctors in America for over 20 years
Sat Dev Batish Ph.D., FACMG, FAAN is the Chief Director for Athena Diagnostics (Quest Diagnostics), Massachusetts. His responsibilities include but are not limited to reviewing clinical cases and provide consultations to neurologists and geneticists across the USA. He is also acting as Specialty Director (Neurogenetics) at Harvard Medical School in Clinical Genomics Program and University of Massachusetts Medical School Residency teaching program. Dr. Batish has 28 years of experience in diagnostics research, laboratory medicine and regulatory affairs. During his 20-year tenure at Athena, he has been involved in launching several new genetic and immunology tests using state of the art technologies.